• Study of Lurbinectedin and Irinotecan for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France Italy Spain

  • Study of Acalabrutinib for Patients with Waldenström Macroglobulinemia

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France Greece Italy

  • Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Germany Ireland Spain

  • Study on Cefoxitin and Sodium Chloride for Preventing Infections After Colorectal Surgery

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor

    Not recruiting

    3 1
    Investigated drugs:
    Austria Belgium France Italy The Netherlands Poland +2

  • Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Czechia Greece Hungary Italy +5

  • Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Portugal Spain

  • Study on the Safety of Vonafexor for Patients with Alport Syndrome at Risk of Progression

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Spain

  • Study on Deferiprone for Preventing Secondary Degeneration in Stroke Patients

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Enzalutamide and Talazoparib for Treating Metastatic Hormone-Naïve Prostate Cancer in Patients

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

powered by